1	Rarely	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	such	_	_	JJ	_	_	_	_	_
4	influenza	_	_	NN	_	_	_	_	_
5	vaccines	_	_	NNS	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	cause	_	_	VB	_	_	_	_	_
8	allergic	_	_	JJ	_	_	_	_	_
9	reactions	_	_	NNS	_	_	_	_	_
10	such	_	_	JJ	_	_	_	_	_
11	as	_	_	IN	_	_	_	_	_
12	hives	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	rapid	_	_	JJ	_	_	_	_	_
15	swelling	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	deeper	_	_	JJR	_	_	_	_	_
18	skin	_	_	NN	_	_	_	_	_
19	layers	_	_	NNS	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	tissues	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	asthma	_	_	NN	_	_	_	_	_
24	or	_	_	CC	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	severe	_	_	JJ	_	_	_	_	_
27	multisystem	_	_	NN	_	_	_	_	_
28	allergic	_	_	JJ	_	_	_	_	_
29	reaction	_	_	NN	_	_	_	_	_
30	due	_	_	JJ	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	hypersensitivity	_	_	NN	_	_	_	_	_
33	to	_	_	TO	_	_	_	_	_
34	certain	_	_	JJ	_	_	_	_	_
35	vaccine	_	_	NN	_	_	_	_	_
36	components	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Live	_	_	JJ	_	_	_	_	_
2	vaccines	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	given	_	_	VBN	_	_	_	_	_
5	via	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	nasal	_	_	JJ	_	_	_	_	_
8	spray	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	commonly	_	_	RB	_	_	_	_	_
13	cause	_	_	VB	_	_	_	_	_
14	runny	_	_	JJ	_	_	_	_	_
15	nose	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	nasal	_	_	JJ	_	_	_	_	_
18	congestion	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	cough	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	can	_	_	MD	_	_	_	_	_
24	less	_	_	RBR	_	_	_	_	_
25	frequently	_	_	RB	_	_	_	_	_
26	cause	_	_	VB	_	_	_	_	_
27	sore	_	_	JJ	_	_	_	_	_
28	throat	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	low	_	_	JJ	_	_	_	_	_
31	grade	_	_	NN	_	_	_	_	_
32	fever	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	irritability	_	_	NN	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	head-	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	muscle-	_	_	NN	_	_	_	_	_
39	aches	_	_	NNS	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Wheezing	_	_	VBG	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	vomiting	_	_	NN	_	_	_	_	_
4	episodes	_	_	NNS	_	_	_	_	_
5	have	_	_	VBP	_	_	_	_	_
6	been	_	_	VBN	_	_	_	_	_
7	described	_	_	VBN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	children	_	_	NNS	_	_	_	_	_
10	receiving	_	_	VBG	_	_	_	_	_
11	live	_	_	JJ	_	_	_	_	_
12	influenza	_	_	NN	_	_	_	_	_
13	vaccines	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	MM	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	What	_	_	WP	_	_	_	_	_
7	action	_	_	NN	_	_	_	_	_
8	has	_	_	VBZ	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	WHO	_	_	NNP	_	_	_	_	_
11	taken	_	_	VBN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	if	_	_	IN	_	_	_	_	_
14	any	_	_	DT	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	insure	_	_	VB	_	_	_	_	_
18	vaccines	_	_	NNS	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	available	_	_	JJ	_	_	_	_	_
21	?	_	_	.	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	KM	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	During	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	first	_	_	JJ	_	_	_	_	_
9	stages	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	pandemic	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	2009	_	_	CD	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	Director-General	_	_	NNP	_	_	_	_	_
18	highlighted	_	_	VBD	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	need	_	_	NN	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	make	_	_	VB	_	_	_	_	_
23	vaccine	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	medicines	_	_	NNS	_	_	_	_	_
26	available	_	_	JJ	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	countries	_	_	NNS	_	_	_	_	_
29	who	_	_	WP	_	_	_	_	_
30	would	_	_	MD	_	_	_	_	_
31	be	_	_	VB	_	_	_	_	_
32	unable	_	_	JJ	_	_	_	_	_
33	to	_	_	TO	_	_	_	_	_
34	access	_	_	VB	_	_	_	_	_
35	them	_	_	PRP	_	_	_	_	_
36	on	_	_	IN	_	_	_	_	_
37	their	_	_	PRP$	_	_	_	_	_
38	own	_	_	JJ	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	WHO	_	_	NNP	_	_	_	_	_
4	pandemic	_	_	NN	_	_	_	_	_
5	vaccine	_	_	NN	_	_	_	_	_
6	donation	_	_	NN	_	_	_	_	_
7	programme	_	_	NN	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	first	_	_	RB	_	_	_	_	_
10	established	_	_	VBN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	all	_	_	DT	_	_	_	_	_
13	countries	_	_	NNS	_	_	_	_	_
14	were	_	_	VBD	_	_	_	_	_
15	surveyed	_	_	VBN	_	_	_	_	_
16	by	_	_	IN	_	_	_	_	_
17	WHO	_	_	NNP	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	95	_	_	CD	_	_	_	_	_
21	identified	_	_	VBN	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	having	_	_	VBG	_	_	_	_	_
24	no	_	_	DT	_	_	_	_	_
25	access	_	_	NN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	pandemic	_	_	JJ	_	_	_	_	_
28	vaccines	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	therefore	_	_	RB	_	_	_	_	_
32	eligible	_	_	JJ	_	_	_	_	_
33	for	_	_	IN	_	_	_	_	_
34	donations	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Based	_	_	VBN	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	pledges	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	donated	_	_	VBN	_	_	_	_	_
7	vaccine	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	plan	_	_	NN	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	prepared	_	_	VBN	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	two	_	_	CD	_	_	_	_	_
16	phase	_	_	NN	_	_	_	_	_
17	approach	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	supply	_	_	VB	_	_	_	_	_
20	sufficient	_	_	JJ	_	_	_	_	_
21	vaccines	_	_	NNS	_	_	_	_	_
22	for	_	_	IN	_	_	_	_	_
23	10	_	_	CD	_	_	_	_	_
24	%	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	population	_	_	NN	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	these	_	_	DT	_	_	_	_	_
30	countries	_	_	NNS	_	_	_	_	_
31	;	_	_	:	_	_	_	_	_
32	an	_	_	DT	_	_	_	_	_
33	initial	_	_	JJ	_	_	_	_	_
34	supply	_	_	NN	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	cover	_	_	VB	_	_	_	_	_
37	health	_	_	NN	_	_	_	_	_
38	workers	_	_	NNS	_	_	_	_	_
39	and	_	_	CC	_	_	_	_	_
40	other	_	_	JJ	_	_	_	_	_
41	essential	_	_	JJ	_	_	_	_	_
42	workers	_	_	NNS	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	equivalent	_	_	JJ	_	_	_	_	_
45	to	_	_	TO	_	_	_	_	_
46	2	_	_	CD	_	_	_	_	_
47	%	_	_	NN	_	_	_	_	_
48	of	_	_	IN	_	_	_	_	_
49	the	_	_	DT	_	_	_	_	_
50	population	_	_	NN	_	_	_	_	_
51	,	_	_	,	_	_	_	_	_
52	and	_	_	CC	_	_	_	_	_
53	a	_	_	DT	_	_	_	_	_
54	second	_	_	JJ	_	_	_	_	_
55	supply	_	_	NN	_	_	_	_	_
56	of	_	_	IN	_	_	_	_	_
57	8	_	_	CD	_	_	_	_	_
58	%	_	_	NN	_	_	_	_	_
59	for	_	_	IN	_	_	_	_	_
60	other	_	_	JJ	_	_	_	_	_
61	priority	_	_	NN	_	_	_	_	_
62	groups	_	_	NNS	_	_	_	_	_
63	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	sequencing	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	supply	_	_	NN	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	based	_	_	VBN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	assessments	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	vulnerability	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	pandemic	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	readiness	_	_	NN	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	utilize	_	_	VB	_	_	_	_	_
19	vaccines	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	date	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	25	_	_	CD	_	_	_	_	_
5	countries	_	_	NNS	_	_	_	_	_
6	have	_	_	VBP	_	_	_	_	_
7	received	_	_	VBN	_	_	_	_	_
8	donated	_	_	VBN	_	_	_	_	_
9	H1N1	_	_	NNP	_	_	_	_	_
10	vaccine	_	_	NN	_	_	_	_	_
11	totaling	_	_	VBG	_	_	_	_	_
12	more	_	_	JJR	_	_	_	_	_
13	than	_	_	IN	_	_	_	_	_
14	10	_	_	CD	_	_	_	_	_
15	million	_	_	CD	_	_	_	_	_
16	doses	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	along	_	_	IN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	ancillary	_	_	JJ	_	_	_	_	_
21	supplies	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	15	_	_	CD	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	20	_	_	CD	_	_	_	_	_
5	countries	_	_	NNS	_	_	_	_	_
6	will	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	receiving	_	_	VBG	_	_	_	_	_
9	their	_	_	PRP$	_	_	_	_	_
10	vaccine	_	_	NN	_	_	_	_	_
11	shipments	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	upcoming	_	_	JJ	_	_	_	_	_
15	few	_	_	JJ	_	_	_	_	_
16	weeks	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	25	_	_	CD	_	_	_	_	_
3	countries	_	_	NNS	_	_	_	_	_
4	who	_	_	WP	_	_	_	_	_
5	have	_	_	VBP	_	_	_	_	_
6	received	_	_	VBN	_	_	_	_	_
7	shipments	_	_	NNS	_	_	_	_	_
8	are	_	_	VBP	_	_	_	_	_
9	:	_	_	:	_	_	_	_	_
10	Azerbaijan	_	_	NNP	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	Afghanistan	_	_	NNP	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	Cambodia	_	_	NNP	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	Fiji	_	_	NNP	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	Kiribati	_	_	NNP	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	Kosovo	_	_	NNP	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	Laos	_	_	NNP	_	_	_	_	_
23	PDR	_	_	NNP	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	Maldives	_	_	NNP	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	Mongolia	_	_	NNP	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	Nauru	_	_	NNP	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	Nicaragua	_	_	NNP	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	Papua	_	_	NNP	_	_	_	_	_
34	New	_	_	NNP	_	_	_	_	_
35	Guinea	_	_	NNP	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	Solomon	_	_	NNP	_	_	_	_	_
38	Islands	_	_	NNP	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	Togo	_	_	NNP	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	Tonga	_	_	NNP	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	Vanuatu	_	_	NNP	_	_	_	_	_
45	,	_	_	,	_	_	_	_	_
46	Cuba	_	_	NNP	_	_	_	_	_
47	,	_	_	,	_	_	_	_	_
48	Honduras	_	_	NNP	_	_	_	_	_
49	,	_	_	,	_	_	_	_	_
50	El	_	_	NNP	_	_	_	_	_
51	Salvador	_	_	NNP	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	Kenya	_	_	NNP	_	_	_	_	_
54	,	_	_	,	_	_	_	_	_
55	Samoa	_	_	NNP	_	_	_	_	_
56	,	_	_	,	_	_	_	_	_
57	Tokelau	_	_	NNP	_	_	_	_	_
58	,	_	_	,	_	_	_	_	_
59	Cook	_	_	NNP	_	_	_	_	_
60	Islands	_	_	NNPS	_	_	_	_	_
61	,	_	_	,	_	_	_	_	_
62	Pakistan	_	_	NNP	_	_	_	_	_
63	,	_	_	,	_	_	_	_	_
64	[	_	_	-LRB-	_	_	_	_	_
65	and	_	_	CC	_	_	_	_	_
66	]	_	_	-RRB-	_	_	_	_	_
67	Philippines	_	_	NNP	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	MM	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	Last	_	_	JJ	_	_	_	_	_
7	November	_	_	NNP	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	WHO	_	_	NNP	_	_	_	_	_
11	stated	_	_	VBD	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	H1N1	_	_	NNP	_	_	_	_	_
14	virus	_	_	NN	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	world	_	_	NN	_	_	_	_	_
17	's	_	_	POS	_	_	_	_	_
18	most	_	_	RBS	_	_	_	_	_
19	dominant	_	_	JJ	_	_	_	_	_
20	virus	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Is	_	_	VBZ	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	still	_	_	RB	_	_	_	_	_
4	true	_	_	JJ	_	_	_	_	_
5	?	_	_	.	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	KM	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	On	_	_	IN	_	_	_	_	_
7	February	_	_	NNP	_	_	_	_	_
8	18th	_	_	CD	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	WHO	_	_	NNP	_	_	_	_	_
11	concluded	_	_	VBD	_	_	_	_	_
12	a	_	_	DT	_	_	_	_	_
13	four-day	_	_	JJ	_	_	_	_	_
14	meeting	_	_	NN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	look	_	_	VB	_	_	_	_	_
17	at	_	_	IN	_	_	_	_	_
18	vaccine	_	_	NN	_	_	_	_	_
19	strains	_	_	NNS	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	seasonal	_	_	JJ	_	_	_	_	_
22	influenza	_	_	NN	_	_	_	_	_
23	vaccine	_	_	NN	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	2010	_	_	CD	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	2011	_	_	CD	_	_	_	_	_
29	season	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	part	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	routine	_	_	JJ	_	_	_	_	_
7	work	_	_	NN	_	_	_	_	_
8	that	_	_	WDT	_	_	_	_	_
9	WHO	_	_	NNP	_	_	_	_	_
10	does	_	_	VBZ	_	_	_	_	_
11	twice	_	_	RB	_	_	_	_	_
12	yearly	_	_	RB	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	determine	_	_	VB	_	_	_	_	_
15	vaccine	_	_	NN	_	_	_	_	_
16	strains	_	_	NNS	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	be	_	_	VB	_	_	_	_	_
19	included	_	_	VBN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	upcoming	_	_	JJ	_	_	_	_	_
22	northern	_	_	JJ	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	southern	_	_	JJ	_	_	_	_	_
25	hemisphere	_	_	NN	_	_	_	_	_
26	seasonal	_	_	JJ	_	_	_	_	_
27	influenza	_	_	NN	_	_	_	_	_
28	vaccines	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	During	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	scientific	_	_	JJ	_	_	_	_	_
4	discussions	_	_	NNS	_	_	_	_	_
5	which	_	_	WDT	_	_	_	_	_
6	ended	_	_	VBD	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	18th	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	February	_	_	NNP	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	it	_	_	PRP	_	_	_	_	_
14	was	_	_	VBD	_	_	_	_	_
15	confirmed	_	_	VBN	_	_	_	_	_
16	that	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	overwhelming	_	_	JJ	_	_	_	_	_
19	number	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	influenza	_	_	NN	_	_	_	_	_
22	viruses	_	_	NNS	_	_	_	_	_
23	that	_	_	WDT	_	_	_	_	_
24	were	_	_	VBD	_	_	_	_	_
25	isolated	_	_	VBN	_	_	_	_	_
26	around	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	world	_	_	NN	_	_	_	_	_
29	were	_	_	VBD	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	pandemic	_	_	JJ	_	_	_	_	_
32	H1N1	_	_	NNP	_	_	_	_	_
33	virus	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	experts	_	_	NNS	_	_	_	_	_
3	believe	_	_	VBP	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	based	_	_	VBN	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	this	_	_	DT	_	_	_	_	_
8	information	_	_	NN	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	this	_	_	DT	_	_	_	_	_
11	virus	_	_	NN	_	_	_	_	_
12	will	_	_	MD	_	_	_	_	_
13	continue	_	_	VB	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	one	_	_	CD	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	dominant	_	_	JJ	_	_	_	_	_
20	viruses	_	_	NNS	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	wide	_	_	JJ	_	_	_	_	_
23	circulation	_	_	NN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	coming	_	_	VBG	_	_	_	_	_
27	fall	_	_	NN	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	winter	_	_	NN	_	_	_	_	_
30	season	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	MM	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	Is	_	_	VBZ	_	_	_	_	_
7	there	_	_	EX	_	_	_	_	_
8	anything	_	_	NN	_	_	_	_	_
9	that	_	_	WDT	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	WHO	_	_	NNP	_	_	_	_	_
12	believes	_	_	VBZ	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	be	_	_	VB	_	_	_	_	_
15	very	_	_	RB	_	_	_	_	_
16	important	_	_	JJ	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	public	_	_	NN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	know	_	_	VB	_	_	_	_	_
22	about	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	H1N1	_	_	NNP	_	_	_	_	_
25	?	_	_	.	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	KM	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	overall	_	_	JJ	_	_	_	_	_
3	impact	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	pandemic	_	_	NN	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	moderate	_	_	JJ	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	most	_	_	JJS	_	_	_	_	_
12	people	_	_	NNS	_	_	_	_	_
13	experienced	_	_	VBN	_	_	_	_	_
14	mild	_	_	JJ	_	_	_	_	_
15	symptoms	_	_	NNS	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	illness	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	some	_	_	DT	_	_	_	_	_
4	groups	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	more	_	_	RBR	_	_	_	_	_
7	vulnerable	_	_	JJ	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	have	_	_	VBP	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	higher	_	_	JJR	_	_	_	_	_
12	risk	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	complications	_	_	NNS	_	_	_	_	_
15	or	_	_	CC	_	_	_	_	_
16	severe	_	_	JJ	_	_	_	_	_
17	illness	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	for	_	_	IN	_	_	_	_	_
20	example	_	_	NN	_	_	_	_	_
21	pregnant	_	_	JJ	_	_	_	_	_
22	women	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	infants	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	young	_	_	JJ	_	_	_	_	_
27	children	_	_	NNS	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	people	_	_	NNS	_	_	_	_	_
30	with	_	_	IN	_	_	_	_	_
31	chronic	_	_	JJ	_	_	_	_	_
32	diseases	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Many	_	_	JJ	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	severe	_	_	JJ	_	_	_	_	_
5	cases	_	_	NNS	_	_	_	_	_
6	have	_	_	VBP	_	_	_	_	_
7	been	_	_	VBN	_	_	_	_	_
8	due	_	_	JJ	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	viral	_	_	JJ	_	_	_	_	_
11	pneumonia	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	which	_	_	WDT	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	harder	_	_	JJR	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	treat	_	_	VB	_	_	_	_	_
18	than	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	bacterial	_	_	JJ	_	_	_	_	_
21	pneumonia	_	_	NN	_	_	_	_	_
22	normally	_	_	RB	_	_	_	_	_
23	associated	_	_	VBN	_	_	_	_	_
24	with	_	_	IN	_	_	_	_	_
25	seasonal	_	_	JJ	_	_	_	_	_
26	influenza	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Many	_	_	JJ	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	patients	_	_	NNS	_	_	_	_	_
5	have	_	_	VBP	_	_	_	_	_
6	required	_	_	VBN	_	_	_	_	_
7	intensive	_	_	JJ	_	_	_	_	_
8	care	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	which	_	_	WDT	_	_	_	_	_
11	has	_	_	VBZ	_	_	_	_	_
12	led	_	_	VBN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	intensive	_	_	JJ	_	_	_	_	_
15	care	_	_	NN	_	_	_	_	_
16	units	_	_	NNS	_	_	_	_	_
17	being	_	_	VBG	_	_	_	_	_
18	frequently	_	_	RB	_	_	_	_	_
19	overwhelmed	_	_	VBN	_	_	_	_	_
20	at	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	peak	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	outbreak	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	deaths	_	_	NNS	_	_	_	_	_
5	caused	_	_	VBN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	pandemic	_	_	JJ	_	_	_	_	_
9	influenza	_	_	NN	_	_	_	_	_
10	disease	_	_	NN	_	_	_	_	_
11	occurred	_	_	VBD	_	_	_	_	_
12	among	_	_	IN	_	_	_	_	_
13	younger	_	_	JJR	_	_	_	_	_
14	people	_	_	NNS	_	_	_	_	_
15	than	_	_	IN	_	_	_	_	_
16	is	_	_	VBZ	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	case	_	_	NN	_	_	_	_	_
19	during	_	_	IN	_	_	_	_	_
20	seasonal	_	_	JJ	_	_	_	_	_
21	influenza	_	_	NN	_	_	_	_	_
22	outbreaks	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	including	_	_	VBG	_	_	_	_	_
25	among	_	_	IN	_	_	_	_	_
26	those	_	_	DT	_	_	_	_	_
27	who	_	_	WP	_	_	_	_	_
28	were	_	_	VBD	_	_	_	_	_
29	previously	_	_	RB	_	_	_	_	_
30	healthy	_	_	JJ	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	protect	_	_	VB	_	_	_	_	_
3	people	_	_	NNS	_	_	_	_	_
4	from	_	_	IN	_	_	_	_	_
5	infection	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	avoid	_	_	VB	_	_	_	_	_
8	related	_	_	JJ	_	_	_	_	_
9	severe	_	_	JJ	_	_	_	_	_
10	outcomes	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	H1N1	_	_	NNP	_	_	_	_	_
14	vaccine	_	_	NN	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	an	_	_	DT	_	_	_	_	_
17	important	_	_	JJ	_	_	_	_	_
18	public	_	_	JJ	_	_	_	_	_
19	health	_	_	NN	_	_	_	_	_
20	tool	_	_	NN	_	_	_	_	_
21	as	_	_	RB	_	_	_	_	_
22	long	_	_	RB	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	pandemic	_	_	JJ	_	_	_	_	_
26	H1N1	_	_	NNP	_	_	_	_	_
27	virus	_	_	NN	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	circulating	_	_	VBG	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	causing	_	_	VBG	_	_	_	_	_
32	illness	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Since	_	_	IN	_	_	_	_	_
2	September	_	_	NNP	_	_	_	_	_
3	2009	_	_	CD	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	more	_	_	JJR	_	_	_	_	_
6	than	_	_	IN	_	_	_	_	_
7	75	_	_	CD	_	_	_	_	_
8	Member	_	_	NNP	_	_	_	_	_
9	States	_	_	NNPS	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	territories	_	_	NNS	_	_	_	_	_
12	have	_	_	VBP	_	_	_	_	_
13	implemented	_	_	VBN	_	_	_	_	_
14	immunization	_	_	NN	_	_	_	_	_
15	programmes	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	290	_	_	CD	_	_	_	_	_
19	million	_	_	CD	_	_	_	_	_
20	doses	_	_	NNS	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	pandemic	_	_	NN	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	H1N1	_	_	NNP	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	2009	_	_	CD	_	_	_	_	_
28	vaccine	_	_	NN	_	_	_	_	_
29	have	_	_	VBP	_	_	_	_	_
30	been	_	_	VBN	_	_	_	_	_
31	administered	_	_	VBN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_

